Search
Search

| Catalog Number | Quantity |
|---|---|
| 6943212005 | 5 mL |
| 6943212001 | 1 mL |
The pre-packed column contains CaptureSelect KappaXP Affinity Matrix, which enables the purification of human immunoglobulins and Fab fragments containing the constant domain of the human kappa light chain.
Features of this affinity matrix include:
Free of animal components
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12 to 15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).
Main characteristics
Matrix: agarose-based, epoxide-activated
Average particle size: 65 ± 10 μm
Ligand: CaptureSelect KappaXP affinity ligand
Fab binding capacity: 20–30 g IgG Kappa-Fab/liter resin, depending on residence time
IgG binding capacity: 35–45 g IgG/liter resin, depending on residence time
Elution conditions: 20 mM citric acid or acetic acid, pH 3–4; 100 mM Tris, 1.5 M MgCl2, pH 6
Column dimensions: 7 x 25 mm (1 mL column); 16 x 25 mm (5 mL column)
Max. recommended flow: 5 mL/min. (1 mL column); 10 mL/min. (5 mL column)
Max. operation pressure: 2 bar
Formulation buffer: 20% (v/v) ethanol